News Sections
Eli Lilly Stop Development Of Osteoporosis Drug
Updated May 5, 2013 12:07 AM | Filed under: Network Indiana
 Print    Archive    RSS

(INDIANAPOLIS, IN) - Indianapolis-based Eli Lilly is stopping development of an osteoporosis drug.

The pharmaceutical-maker says a study has shown Arzoxifene met its primary objectives, but the results did not indicate the drug would "represent a meaningful advancement in the treatment of osteoporosis."

« Previous Article
Next Article »

 Print    Archive    RSS

Have a question or comment about a news story? Send it to

Advertise with 1340 AM WBIW
Advertise with 1340 AM WBIW

1340 AM WBIW, Bedford's Place To Talk. Serving Lawrence and surrounding counties since 1948!

© 2017 Ad-Venture Media, Inc. All Rights Reserved. and Listen Live Powered by HPC

Advertise  |  Careers  |  Contests  |  About  |  Feedback